A single or multi-port vascular access device including one or more reservoirs each covered by a needle-penetrable, self-sealing septum. The one or more reservoirs each open to an outlet in a stem to which the catheter is attached. The reservoir may be generally circular or ellipsoid in shape and large enough so that fluid movement into and out of the needle is unimpeded. In order to maximize flow between the reservoir and catheter and to minimize any regions of impeded or low fluid flow where coagulation or cell shearing may occur, the fluid passage leading from the reservoir through the outlet into the catheter is defined by unique tapered and tangential geometries. For example, the outlet surface may be globally tangent along the entire reservoir surface, or may be globally tangent along only one side of the reservoir surface.
|
1. A subcutaneous access device including a port body comprising:
(a) a reservoir; and
(b) an outlet having a proximal tip joined to the reservoir and a distal tip, wherein the shape of the reservoir and the outlet are defined by the inner surface of the port body;
wherein the reservoir and the outlet are in fluid communication and defined by an inner sidewall and an outer sidewall forming lateral boundaries in opposition defining a flow passage along the reservoir to the distal tip of the outlet;
wherein the lateral boundaries transition into an upper surface of the reservoir and a bottom surface of the reservoir via a smooth curve; and
wherein further the inner sidewall is globally tangent along the reservoir surface and the outer sidewall is tapered and transitions from the reservoir to the outlet defined by a radius of curvature R1 having an angle θ that is greater than 90° and up to 225°, which curvature R1 transitions at the proximal tip of the outlet into a curvature R2 extending to the distal tip of the outlet.
21. A subcutaneous access device comprising two port bodies, each port body comprising:
(a) a reservoir; and
(b) an outlet having a proximal tip joined to the reservoir and a distal tip, wherein the shape of the reservoir and the outlet are defined by the inner surface of the port body;
wherein the reservoir and the outlet are in fluid communication and defined by an inner sidewall and an outer sidewall forming lateral boundaries in opposition defining a flow passage along the reservoir to the distal tip of the outlet;
wherein the lateral boundaries transition into an upper surface of the reservoir and a bottom surface of the reservoir via a smooth curve; and
wherein further the inner sidewall is globally tangent along the reservoir surface and the outer sidewall is tapered and transitions from the reservoir to the outlet defined by a radius of curvature R1 having an angle θ that is greater than 90° and up to 225°, which curvature R1 transitions at the proximal tip of the outlet into a curvature R2 extending to the distal tip of the outlet.
4. The device of
7. The device of 5, wherein the catheter is tapered from the port body outlet to the tip of the catheter.
16. The subcutaneous access device of
(a) separately forming at least two pieces; and
(b) joining the at least two pieces together thereby defining the surface of the reservoir and outlet.
|
This application claims the benefit of priority under 35 U.S.C. §119(e) of U.S. Ser. No. 60/942,722, filed Jun. 8, 2007, the entire content of which is incorporated herein by reference.
1. Field of the Invention
The present invention relates generally to vascular access devices and more specifically to subcutaneously implanted catheter ports.
2. Background Information
A variety of implantable devices, known as subcutaneous ports, are utilized to administer therapies that require central venous access through a non-coring needle received by the port, obviating the need for transdermal central venous catheters. For applications such as bodily fluid exchange and/or removal therapies, drug delivery, pheresis, hemofiltration, hemodialysis and other applications that must be periodically repeated, subcutaneous ports are preferable to other methods of accessing a patient's vascular system, such as direct percutaneous introduction of a needle through the patient's skin into a blood vessel or use of transcutaneous catheters.
A variety of subcutaneous ports have been previously described. A subcutaneous port has one or more reservoirs, each covered by a needle-penetrable, self-sealing septum. The reservoir opens up to a stem which connects to a catheter. Current ports 100, an example of which is shown in
The buildup of blood or fluid is known as sludge, and limits the ability of the port to provide fluid flow in and out of the port, reducing the effectiveness, safety and overall useful life of the port. If the port is used to transfuse blood, blood trapped in these dead spaces has the tendency to form clots and block the flow of fluid through the reservoir. An additional limitation of existing designs is that the edges and corners of current designs also prevent the passage of wires through the port to clear a blockage.
Accordingly, there has been a need for an improved implantable, subcutaneous single or multi-port vascular access device for bodily fluid exchange therapies and other drug delivery applications, which include specific geometries exhibiting, for example, increased port patency, reduced dead-flow zones, and increased mixing within the port. Additionally, there has been a need for vascular access devices that are inexpensive, more comfortable, longer lasting, and easier to locate within the patient's body and suitable for both low and high volume transfer of fluids.
The present invention is based on the discovery of unique geometries for subcutaneous vascular access ports having improved flow properties.
Accordingly, the present invention provides a subcutaneous single or multi-port vascular access device. The device includes a port body including a reservoir and an outlet in fluid communication. The shape of the reservoir and the outlet are defined by the inner surface of the port body having opposed sidewalls which, for convenience, shall be referred to herein as an inner an outer sidewall forming lateral boundaries and defining a flow passage along the reservoir toward the distal tip of the outlet. The inner sidewall may be globally tangent along the reservoir surface, in its entirety or part thereof, and the outer sidewall is tapered from the reservoir to the distal tip of the outlet.
The ports of the present invention include one or more reservoirs covered by one or more needle-penetrable, self-sealing septums. The reservoir(s) collectively open to an outlet to which a catheter may be attached at the distal tip of the outlet. Accordingly, in one aspect, the port may be used with either a fixed or detachable catheter, with the outlet having the appropriate shape to connect with the catheter.
The ports incorporated in the vascular access devices of the present invention exhibiting improved flow properties encompass various geometries. In one aspect, the internal shape of the port body defining the flow path of the reservoir and outlet is such that the outer sidewall transitions from the reservoir to the outlet defined by a radius of curvature R1 and extends to the distal tip of the outlet.
In another aspect, the internal shape of the port body defining the flow path of the reservoir and outlet is such that the outer sidewall transitions from the reservoir to the outlet defined by a radius of curvature R1 and linearly extends to the distal tip of the outlet.
In one aspect, the internal shape of the port body defining the flow path of the reservoir and outlet is such that the outer sidewall transitions from the reservoir to the outlet defined by a radius of curvature R1 and extends arcuately at a constant radius to the distal tip of the outlet.
In another aspect, the internal shape of the port body defining the flow path of the reservoir and outlet is such that the outer sidewall transitions from the reservoir to the outlet defined by a radius of curvature R1 and extends curvilinearly to the distal tip of the outlet. Accordingly, the internal shape of the port body defining the flow path of the reservoir and outlet may be such that the outer sidewall transitions from the reservoir to the outlet defined by a radius of curvature R1 and extends curvilinearly on a path defined by multiple radii, Rn. In a preferred aspect, the outer sidewall transitions from the reservoir to the outlet defined by a radius of curvature R1 and extends curvilinearly on a path defined by one additional radius R2 or two additional radii R2 and R3.
In yet another preferred aspect, the internal shape of the port body defining the flow path of the reservoir and outlet is such that the outer sidewall transitions from the reservoir to the outlet defined by a radius of curvature R1 and extends to the distal tip of the outlet on a splined path.
The vascular access devices of the present invention may include a single port or include multiple ports. In a preferred aspect, the multi-port device includes two ports, however, more than two ports may be incorporated into the device. In a device that includes multiple ports, the ports may be identical in shape, mirror images, or of different shape.
In one aspect, the reservoir is a chamber that may be generally ellipsoid or circular in shape. However, the reservoir may be of any smoothly curved shape which attributes improved flow rate and mixing of the fluid in the reservoir. In one aspect, the reservoir is large enough so that fluid movement into and out of the needle is unimpeded and small enough to keep the flow rate up and to use a minimal amount of fluid for flushing.
The present invention provides a vascular access device having a reservoir and outlet shaped such that the flow is maximized from the reservoir through the outlet into the catheter. In one aspect, at least the outer outlet sidewall is globally tangent along the entire reservoir surface, or the inner sidewall surface so that the reservoir/outlet (the cavity) has, for example, generally a teardrop shape. In another aspect, only the outer outlet sidewall is globally tangent along only one side of the reservoir surface so that the cavity has generally a nautilus shape, which has the benefit of promoting circular motion within the cavity. In a preferred aspect, the outlet's outer sidewall surface is globally tangent along one side of the reservoir and tapered along the opposing inner sidewall.
The reservoir's internal cavity surface is smooth and broad to minimize any sources of impeded flow in order to minimize regions of low flow where coagulation may occur. In one configuration, however, the floor of the internal surface of the reservoir cavity is dimpled to minimize the volume of fluid that may collect in the central region of the reservoir cavity.
In one further aspect, in order to increase flow between the needle and the reservoir and to reduce the regions of low flow in the reservoir, the underside of the septum is concave to match the curve of the reservoir. In another aspect, a dimple in the septum that generally mirrors the bottom of the dimpled reservoir configuration results in a cross-sectional shape that minimizes where blood flow is reduced and coagulation may occur. In yet another aspect, one or more dimples may be off center and configured such that the height does not inhibit the flow of fluid from the needle.
The edge of the reservoir body surrounding and adjacent to the septum is designed to be tactilely identifiable through the skin. In one aspect, the edge is raised above the level of the septum. The edge may have a radius that is small enough to be easily sensed through the skin, but large enough for patient comfort and prevents skin erosion. Alternatively, the septum 18 may be raised above the edge of the port 70 as shown in
The vascular access device of the present invention is suitable for use with various designs of catheters depending on the particular application desired. For example, the distal end of the catheter may be terminated by any type of tip configuration that is desired, such as blunt, step, and split tips. In one aspect, the tip configurations include those that have comparable forward and reverse flow. In another aspect, the catheter may be tapered from its attachment point to the tip of the outlet 22 along the length of the catheter. The taper may travel the entire length of the catheter or any portion thereof.
The vascular access device of the present invention may include a port body that is fabricated from a single piece of stock material as one unitary piece. However, in a preferred aspect, the port body includes at least two pieces separately fabricated, wherein one of the pieces does not include the septum. Accordingly, a port body of a device of the present invention is made by a process that includes: a) separately forming at least two pieces; and b) joining the pieces together thereby defining the surface of the reservoir and outlet. In a preferred aspect, two pieces are separately formed, including for example, an upper piece and a bottom piece.
The upper and bottom pieces of the port body are preferably each of unitary construction, each being formed from a single piece of stock. Alternatively, the pieces may be formed from stock of multiple types of materials. When joined together, both the upper and bottom pieces form the entire reservoir/outlet configuration and may also form additional features, such as an elongated outlet stem including means for attachment to a catheter. Such means may include locking features, such as ribs or barbs being incorporated on the outside of the elongated stem.
The present invention derives from the discovery that providing a globally tangential, preferably tapered tangential, transition from a vascular access port to its outlet port will significantly improve the flow properties of the device. Fluid flow and resistance through the port body to the catheter are critical factors in preventing dead-zones and cell shearing leading to clotting in fluids such as blood. Accordingly, the present invention provides a vascular access device including uniquely shaped ports designed to improve fluid flow and mixing thereof through the port.
In one embodiment, the present invention is a vascular access device for subcutaneous implantation including a port 10 for use with a catheter 12 connected to the port 10, as shown in
Increased patient comfort following subcutaneous implantation is enhanced by smoothing all of the outer surfaces of the port, while maintaining a flat bottom for location within the body. While the port of the present invention is preferably constructed out of durable materials, such as metals, alloys, and the like, the port of the present invention is designed with minimal stress raising geometries so that the port can be made from less strong materials, such as plastics, while retaining all aspects of longevity and functionality. In a preferred aspect, the port is constructed from polysulfone or delrin. Additionally, the internal surface of defining the reservoir and the outlet may further include various types of coatings. For example, when plastics are used to construct the port, internal coatings, such as alloys or metals, may be employed to protect the internal surface from being scratched or deformed by the needle. In a preferred aspect, the internal surface is chromed.
A variety of plastics and/or polymeric materials are well known in the art and suitable for use in subcutaneous applications such as the device of the present invention. One advantage of plastics is that most are compatible with magnetic resonance imaging (MRI). Plastics are generally non-conducting, so that, during an MRI procedure, eddy currents that greatly reduce the quality of the MRI image at the location of the metallic/conducting material are significantly reduced. Additionally the metal parts heat up and may cause tissue damage.
The reservoir 16 is a chamber that is generally ellipsoid or circular in shape, but maybe be any smooth curved shape that improves fluid flow. The ellipsoid may be wider than it is high, circular, or higher than it is wide. The minimum height of reservoir 16 is such that there is sufficient room so that fluid movement into and out of the side hole of the Huber needle is unimpeded. The reservoir 16 cannot be too large otherwise the fluid flow rate is not high enough to clean the walls on flushing, as described below. Another parameter for the size of the reservoir 16 is the desire to be able to flush the system with a minimal amount of saline or other flushing fluid, on the order of about 10 ml of fluid.
As shown in
A variety of needle designs may be used in combination with the present invention. In one aspect the needle is a blunt tipped needle that may be introduced over a trocar. In a preferred aspect, fluid is expelled from the tip of the needle and directed toward the bottom of the reservoir such that the fluid is deflected from the bottom surface creating a vortex or torroidal flow.
The reservoir 16 opens up to an outlet 28 defining a flow passage through the reservoir 16 and the aperture 26 at the distal tip of the outlet 28 to which the catheter 12 is attached. The combination of the reservoir 16 and bore through outlet 28 defines the totality of the open space in the port and is identified herein as “the cavity.” Fluid moves between the catheter lumen 24 and the outlet 28 via an aperture 26 at the distal tip of the outlet 28.
The port body 14 includes a reservoir 16 and an outlet 28 in fluid communication having defined geometries for maximizing fluid flow through the defined flow passage. Therein the shape of the reservoir 16 and the outlet 28 (together, the cavity) are defined by the inner surface of the port body, including an inner sidewall 100 and an outer sidewall 110 forming lateral boundaries defining a flow passage along the reservoir 16 to aperture 26 at the distal tip of the outlet 28 (see, for example,
In one aspect, the stem 22 and aperture 26 are shaped to enable attachment of the catheter 12 to stem 22, and so their diameters are dictated by the catheter parameters, including the size and shape of the cross-section of the associated catheter lumen 24, which may include shapes such as those shown in
The outlet 28 is shaped to maximize flow between the reservoir 16 and the catheter lumen 24. For example, in the outlet 28 of
In the outlet of
While keeping the inner sidewall 100 globally tangent along the reservoir surface and the outer sidewall 110 tapered from the reservoir 16 to the distal tip of the outlet 28, in various embodiments, the flow path of the reservoir 16 may be configured by altering the taper of the outer sidewall 110 as it extends to the distal tip of the outlet 28.
As such, in one aspect, the internal shape of the port body defining the flow path of the reservoir 16 and outlet 28 is such that the outer sidewall 110 tapers from the reservoir 16 to the outlet 28 defined by a radius of curvature R1 and linearly extends to the distal tip of the outlet. As used herein, linearly is intended to mean a path that is substantially straight.
In another aspect, the internal shape of the port body defining the flow path of the reservoir 16 and outlet 28 is such that the outer sidewall 110 tapers from the reservoir 16 to the outlet 28 defined by a radius of curvature R1 and extends arcuately at a constant radius R1 to the distal tip of the outlet. As used herein, arcuately is intended to mean a path that is curved or bowed.
In a further aspect, the internal shape of the port body defining the flow path of the reservoir 16 and outlet 28 is such that the outer sidewall 110 tapers from the reservoir 16 to the outlet 28 defined by a radius of curvature R1 and extends curvilinearly to the distal tip of the outlet. As used herein, curvilinearly means a path that is characterized by one or more curves defined by one or more radii. Accordingly, a curvilinearly extending taper of the outer sidewall 110 may be such that the outer sidewall 110 tapers from the reservoir to the outlet defined by a radius of curvature R1 and extends curvilinearly on a path defined by multiple radii, Rn as shown in
In yet another aspect, the taper of the outer sidewall 110 is defined by a radius of curvature R1 and extends to the distal tip of the outlet 28 on a splined path. As used herein, splined means a smooth path characterized by one or more spline functions. For example, in
Throughout the various embodiments wherein the outer sidewall 110 taper is defined by various geometries, the transition from the reservoir 16 to the outlet 28 defined by radius R1 can begin at any point along the outer sidewall 110 as defined by the angle θ as shown in
To maximize flow, the inner sidewall 100 is globally tangent along the reservoir surface 32. In one aspect the inner sidewall 100 may further include a splined configuration as shown in
The cavity is shaped to minimize regions of low flow within the port 10 where coagulation may occur. The reservoir 16 of
As noted above, ports of the prior art cannot be cleaned or cleared by wires following use. Thus an advantage of the present invention is that the smoothing of the internal features of the port enables cleaning or clearing with a wire. Additionally, the internal features of the port provides access for additional devices and/or allows additional medical procedures. For example, the port shape allows access to a cytology brush for performing cell sampling with in the internal port structure. In another aspect, electrodes may be passed through the port providing access to the vasculature or heart to determine electrophysiological characteristics. In yet another aspect, the port design allows for passage of additional catheters through the port body.
The septum 18 is shaped so that flow between the needle 20 and the reservoir 16 is increased over that of ports of the prior art. Additionally the septum 18 may be shaped so that regions of low flow within the port 10 where coagulation may occur is reduced relative to ports of the prior art.
One method by which increased flow is accomplished is shown in
In the septum 18 of
The area of the port body 14 surrounding the septum 18 is designed so that the location of the septum 18 is tactilely identifiable through the skin. This is achieved in one embodiment by raising the edge 50 of the port body 14 surrounding the septum 18 above the level of the septum 18, as can be seen in
Optionally, as shown in
The port 10 of the present invention is intended to be used with either a fixed catheter, that is a catheter that cannot be detached from the stem 22, or a detachable catheter. The stem 22 is designed to accommodate the appropriate catheter using attachments known in the art. The length of a detachable catheter can be adjusted by removing it from the port, trimming the proximal end, and reattaching it to the port. In this way, catheters with exotic tip configurations can be used. In instances where a blunt tip is sufficient, the catheter can be fixed and the length can be adjusted by cutting the distal end of catheter.
The distal end 60 of the catheter 12 is terminated by any type of tip configuration that is desired. There are a number of tip configurations that currently exist in the hemodialysis industry including, but not limited, to the blunt tip, shown in
Tip configurations contemplated for use by the present invention include those that have comparable forward and reverse flow. One prior art tip configuration, shown in
Optionally, the diameter of the catheter 12 decreases along its length from the proximal end in order to improve flow, to improve the seal of the vascular puncture 11 around the catheter 12, or to reduce the propensity for kinking of the catheter 12.
Conventional methods for fabricating vascular access devices employ a method in which the entire reservoir of the port is hollowed out from a single piece of stock. For example, the port body is not fabricated from at least two pieces and joined together to define the reservoir and outlet, wherein one of the pieces is not the septum. For example, an upper 200 and lower piece 210 of the port body is fabricated separately as shown in
Accordingly, in one aspect the vascular access device of the present invention is made by a process including separately forming at least two separate pieces; and joining the pieces together thereby defining the surface of the reservoir and outlet. The pieces that are separately fabricated and joined may be derived by slicing the port design along any axis to produce, for example, two pieces. Likewise, additional slices of the port design may produce more than two pieces (for example, quarters or eighths or the like). In a preferred aspect, the port design is sliced once latitudinally producing an upper piece 200 and a bottom piece 210 that are to be fabricated separately as shown in
The pieces may be formed from a variety of materials suitable for implantation and formed by methods appropriate to the material used.
Thus it has been shown and described an implantable catheter port which satisfies the objects set forth above.
The following examples are intended to illustrate but not limit the invention.
This example illustrates the superior flow rate characteristics of the tapered and tangential port design of the present invention. A Flow Visualization Experiment (FVE) was conducted showing the benefits of a tangent and tapered outlet port design versus both a tangent but not tapered outlet port design and a centered outlet port design typically used in the art.
The following port configurations were utilized to conduct the FVE. A tangent and tapered (TT) port design was constructed having a chamber volume of 0.742 ml and having a hydraulic diameter of the outlet (4 times the area of the outlet divided by the perimeter of the outlet) of 2.073 mm. The tangent and tapered design is shown in
A tapered not tangent (TNT) port design was constructed having a chamber volume of 0.847 ml and having a hydraulic diameter of the outlet (4 times the area of the outlet divided by the perimeter of the outlet) of 1.729 mm. The tangent not tapered design is shown in
A centered tapered (C) port design was constructed having a chamber volume of 0.766 ml and having a hydraulic diameter of the outlet (4 times the area of the outlet divided by the perimeter of the outlet) of 1.168 mm. The center tapered design is shown in
The FVE was conducted using the above described port designs in the following stepwise fashion.
Step 1: A hollow, cylindrical, and blunt tipped needle was inserted into a transparent tangent and tapered port reservoir filled with blue water based ink via an affixed septum of a design that minimizes the amount of intrusion of the septum into the reservoir.
Step 2: Water was then pumped through the needle into the reservoir at a prescribed flow rate of 10, 40, 150, or 300 ml/min while a 30 frame-per-second video camera monitored and recorded the visualization of the flow.
Step 3: The recorded video was then loaded into a numerical analysis software, where the intensity of the pixels of each frame of the video was stored in a matrix.
Step 4. For each frame in the video, the intensity of each pixel in a single frame was summed.
Step 5. The sums of the intensities of all frames for a given flow rate were then plotted as a function of time along with expected values for the predicted intensities for that same given flow rate as predicted by,
where X is the sum of the intensities, C is the starting intensity, F is the flow-rate of water into the reservoir, V is the volume of the reservoir, and t is the elapsed time and Equation (1) is the solution to the differential equation which represents perfect mixing within the reservoir,
Step 6. The times at which the sum of the measured pixel intensities has e−1, e−2, and e−3 percent of the initial amount of pixel intensity remaining was then taken from the plot and compared to the pixel intensities of each respective decrement as predicted by equation (1).
Step 7. The difference between the expected time of each decrement and the actual time of each decrement was then compared.
Step 8. This procedure was repeated for each port design.
The FVE demonstrates that the tangent and tapered outlet port design minimizes the difference between the measured and the expected decrement times for the flow rates, particularly flows of 10 and 40 ml/min.
This measure of improvement in flow is of particular value because low flow-rates, such as 10 and 40 ml/min, are representative of three important vascular access therapies or procedures: 1) fluid removal from fluid overloaded patients having Congestive Heart Failure (CHF); 2) the flushing of a subcutaneous port by hand and 3) the injection of chemotherapeutic agent by hand or by gravity.
Fluid may be extracted from fluid overloaded congestive heart failure patients by implanting a port of tangent and tapered outlet design and removing blood from one reservoir and replacing it through the other reservoir at a flow rate of between 10 and 40 ml/min.
As demonstrated by the minimal difference of the decrements (theoretical versus actual) the tangent and tapered outlet port observes closer to perfect mixing within the reservoir, which corroborates the appearance of fewer dead-flow zones in the original videos of the experiment.
With the presence of fewer dead zones it is expected that in a blood transfer application, such as that of fluid removal from CHF patients, a port having a tangent and tapered outlet is expected to have a longer patency, as the propensity for thrombosis is expected to be proportional to the presence of dead zones.
Better mixing within the reservoir, as indicated by lower decrement times, is also very important for achieving a good flush for clearance of the port, which is important for increasing the patency of ports. Typically, a nurse can inject fluid at a flow rate of up to approximately 10 ml at 40 ml/min by hand. Thus having better port clearance at low flow rates is critically important.
Although the invention has been described with reference to the above example, it will be understood that modifications and variations are encompassed within the spirit and scope of the invention. Accordingly, the invention is limited only by the following claims.
Powley, Nicholas R., Kveen, Graig Leonard, Geer, Donald, Allex, Steven, Zawacki, John Arthur
Patent | Priority | Assignee | Title |
10406274, | Jun 02 2017 | Accessing assembly for hemodialysis administration | |
10463845, | Jan 23 2013 | C R BARD, INC | Low-profile access port |
11420033, | Jan 23 2013 | C R BARD, INC | Low-profile single and dual vascular access device |
11464960, | Jan 23 2013 | C. R. Bard, Inc.; C R BARD, INC | Low-profile single and dual vascular access device |
D870264, | Sep 06 2017 | C R BARD, INC | Implantable apheresis port |
D885557, | Sep 06 2017 | C. R. Bard, Inc. | Implantable apheresis port |
Patent | Priority | Assignee | Title |
5041098, | May 19 1989 | GRANTADLER CORPORATION | Vascular access system for extracorporeal treatment of blood |
5399168, | Aug 29 1991 | C R BARD, INC | Implantable plural fluid cavity port |
5704915, | Feb 14 1995 | Arrow International, Inc; ARROW-THEREX CORPORATION; ARROW INFUSION CORPORATION | Hemodialysis access device |
5713859, | Jan 18 1994 | VASCA, INC | Implantable vascular device |
5755780, | Jan 01 1994 | Vasca, Inc. | Implantable vascular device |
6962577, | Apr 26 2000 | VERSAGO VASCULAR ACCESS, INC | Implantable hemodialysis access device |
6997914, | Apr 02 2001 | RITA MEDICAL SYSTEMS, LLC; AngioDynamics, Inc | Implantable access port |
7351233, | Oct 14 2003 | Subcutaneous vascular access port, needle and kit, and methods of using same | |
7445614, | Oct 25 2002 | B. Braun Medical SAS | Subcutaneously implantable access port |
20060058744, | |||
20060084929, | |||
20060100592, | |||
20060178647, | |||
20060184141, | |||
20060264898, | |||
20070073250, | |||
20080086099, | |||
WO141858, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jun 09 2008 | R4 Vascular, Inc. | (assignment on the face of the patent) | / | |||
Jul 16 2008 | KVEEN, GRAIG LEONARD | R4 VASCULAR, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 022021 | /0944 | |
Jul 17 2008 | POWLEY, NICHOLAS R | R4 VASCULAR, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 022021 | /0944 | |
Jul 17 2008 | ALLEX, STEVEN | R4 VASCULAR, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 022021 | /0944 | |
Jul 17 2008 | ZAWACKI, JOHN ARTHUR | R4 VASCULAR, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 022021 | /0944 | |
Jul 22 2008 | GEER, DONALD | R4 VASCULAR, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 022021 | /0944 | |
Jun 12 2009 | R4 VASCULAR, INC | BLACK SAND ASSOCIATES, LLC | SECURITY AGREEMENT | 022831 | /0463 | |
Jul 13 2009 | BLACK SAND ASSOCIATES, LLC | R4 VASCULAR, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 022953 | /0102 | |
Jul 07 2010 | R4 VASCULAR, INC | VOLCANO CAPITAL LLC | SECURITY AGREEMENT | 024660 | /0486 | |
May 13 2015 | R4 VASCULAR, INC | VECTOR CORP , LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 035632 | /0076 |
Date | Maintenance Fee Events |
Jul 31 2015 | REM: Maintenance Fee Reminder Mailed. |
Dec 20 2015 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Dec 20 2014 | 4 years fee payment window open |
Jun 20 2015 | 6 months grace period start (w surcharge) |
Dec 20 2015 | patent expiry (for year 4) |
Dec 20 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
Dec 20 2018 | 8 years fee payment window open |
Jun 20 2019 | 6 months grace period start (w surcharge) |
Dec 20 2019 | patent expiry (for year 8) |
Dec 20 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
Dec 20 2022 | 12 years fee payment window open |
Jun 20 2023 | 6 months grace period start (w surcharge) |
Dec 20 2023 | patent expiry (for year 12) |
Dec 20 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |